Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. The company was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-15 |
2024-03 |
0 |
-0.63 |
N/A |
N/A |
2024-03-28 |
2023-12 |
0 |
-1.46 |
N/A |
N/A |
2023-11-09 |
2023-09 |
0 |
-1.47 |
N/A |
N/A |
2023-08-09 |
2023-06 |
-3.48 |
-3.1 |
0.38 |
10.92% |
2023-05-11 |
2023-03 |
0 |
-7.76 |
N/A |
N/A |
2023-03-22 |
2022-12 |
-10.5 |
-9 |
1.5 |
14.29% |
Date |
Firm |
Action |
From |
To |
2023-09-21 |
Maxim Group |
Upgrade |
Hold |
Buy |
2023-06-25 |
HC Wainwright & Co. |
Upgrade |
Buy |
Buy |
2023-06-06 |
HC Wainwright & Co. |
Upgrade |
Buy |
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2023-06-27 |
ALTOMARI ALFRED |
Chief Executive Officer |
47.75K |
Stock Award(Grant) |
2023-06-07 |
BARBARI SHARON SURREY A |
Director |
974.00 |
Stock Award(Grant) |
2023-06-07 |
CARSON SANDRA |
Director |
974.00 |
Stock Award(Grant) |
2023-10-02 |
COIANTE SCOTT M |
Chief Financial Officer |
20.08K |
Stock Award(Grant) |
2023-06-27 |
CONWAY ROBERT G. |
Officer |
13.53K |
Stock Award(Grant) |
2023-06-07 |
FISCHER SETH H Z |
Director |
976.00 |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Armistice Capital, LLC |
122.00K |
359.90K |
6.33% |
2023-06-29 |
State Street Corporation |
10.84K |
31.99K |
0.56% |
2023-06-29 |
Blackrock Inc. |
6.06K |
17.88K |
0.31% |
2023-06-29 |
Tower Research Capital LLC (TRC) |
2.71K |
8.00K |
0.14% |
2023-06-29 |
Investor AB |
1.75K |
5.17K |
0.09% |
2023-06-29 |
Royal Bank of Canada |
758.00 |
2.24K |
0.04% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-05-30 |
Fidelity Extended Market Index Fund |
4.10K |
15.53K |
0.21% |
2023-06-29 |
Vanguard Extended Market Index Fund |
3.77K |
11.11K |
0.20% |
2023-05-30 |
Fidelity Series Total Market Index Fund |
502.00 |
1.90K |
0.03% |
2023-08-30 |
iShares Core S&P Total U.S. Stock Market ETF |
295.00 |
767.00 |
0.02% |
Split |
Date |
1 : 50 |
2023-04-11 |
1 : 40 |
2022-04-27 |